Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Finance > UK Economic recovery behind global benchmark but outlook brightens after vaccine breakthrough
    Finance

    UK Economic recovery behind global benchmark but outlook brightens after vaccine breakthrough

    Published by linker 5

    Posted on December 21, 2020

    6 min read

    Last updated: January 21, 2026

    graphicstock-businessman-using-smart-phone-and-laptop-with-graph-statistical-analysis-business-success-concept_HOXgPAoPlil
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    • The UK’s economic recovery from Covid-19 remained behind the global benchmark in November, with tourism and recreation businesses falling furthest behind.
    • Total UK private sector output fell at a much slower pace than in Q2 2020 during November, as the latest lockdown measures hit consumer facing sectors and their suppliers hardest.
    • Ten out of fourteen UK sectors recorded output growth in November, with the biggest month-on-month upticks seen among manufacturers of technology equipment and household goods.
    • News of effective coronavirus vaccines boosted confidence in firms’ 12-month outlook to heights not seen since the start of the pandemic.

    The pace of the UK’s economic recovery remained behind the global benchmark in November, according to the latest Lloyds Bank UK Recovery Tracker. However, news of the first effective coronavirus vaccine buoyed business confidence for the year ahead.

    The Tracker, working with IHS Markit, provides unique insight into the shape and pace of the UK’s recovery following the disruption caused by Covid-19.

    UK sectors remain behind global benchmark, but ahead of Europe

    Eight of the fourteen UK sectors monitored by the Tracker were behind the global index during November, the same number as in October.

    Tourism and recreation businesses were furthest behind the equivalent global benchmark, with a reading of 15.6 against the global benchmark for the sector of 44.0 as the national lockdown in England came into force. A reading above 50 signals output is rising, while a reading below 50 indicates output is contracting.

    The beverages and food sector (39.9) also fell further behind the equivalent global benchmark (52.4) in November, with producers citing a fall in orders from pubs and restaurants.

    Real estate (40.6) and transportation (47.5) were the only other UK sectors monitored by the Tracker to register an outright decline in output during November. Lockdown measures compounded the fall in demand for commercial property rentals and public transport, as more people worked from home.

    While the UK overall remained behind the global benchmark in November, it still outperformed the European benchmark, with 12 of the 14 UK sectors monitored by the tracker reporting a stronger output performance.

    Only tourism and recreation and beverages and food were behind the European average.

    Manufacturing firms help stop UK output falling to Q2 low

    UK national output fell for the first time in five months during November (49.0). However, the fall was not as steep as the drop measured in March (36.0), April (13.8) and May (30.0), during the first national lockdown.

    This is partly due to manufacturers being able to operate as normal during the latest series of lockdown measures across the UK. Domestic manufacturers outperformed services businesses for a ninth consecutive month in November. Metals and mining led the growth rankings for the third month running (70.7), with automobiles and auto parts in second place again (63.3).

    Ten of the fourteen sectors monitored by the tracker saw overall output growth during November, with six recording faster output growth month-on-month. The biggest uptick was seen among technology equipment manufacturers (61.3 vs 52.7 in October) and producers of household products (52.7 vs. 45.0 in October). The rise in UK technology equipment output mirrored a worldwide rebound in the sector during November, led by the recovery of the global semiconductors industry, which improved trade flows and boosted demand.

    Manufacturers indicated that rising output was partly driven by higher export orders in November, as European clients brought forward purchases before the end of the Brexit transition period. The 31 December deadline also caused stockpiling at factories for the first time since October 2019.

    Vaccine news boosts business optimism for 2021

    While national output fell in November, news of the first effective coronavirus vaccine made UK companies more optimistic about the UK’s recovery in November. In fact, business optimism about the coming 12 months was the highest recorded since the start of the pandemic.

    The number of UK businesses linking news of an effective coronavirus vaccine to an expected rise in their output over the next year was more than five times higher than in October. This index was by far the highest recorded in the UK Recovery Tracker’s history.

    The improved outlook was greatest among the sectors most affected by Covid-19 lockdown measures. Almost two thirds (64%) of tourism and recreation firms and more than two fifths (43%) of real estate businesses predicted their output would rise in the next 12 months, up from 41% and 30% respectively in October.

    The software and services sector also registered a large uptick in confidence month-on-month (69% anticipate growth vs 55% in October) and now has the most positive outlook for the next 12 months of all 14 sectors monitored by the Tracker, followed by healthcare (68% vs 63% in October).

    Jeavon Lolay, Head of Economics and Market Insight, Lloyds Bank Commercial Banking, said: “While the performance of UK services businesses has been acutely affected by the tightening of restrictions and national lockdown measures, there were also positive signs of resilience for the broader economy as a range of sectors reported stronger growth in November. It shows that not only were the mandatory restrictions less onerous than in the spring but that businesses have also adapted well during the pandemic.

    “The news of an effective vaccine saw business expectations improve markedly last month, potentially helping to reverse the fortunes of consumer facing industries that have borne the brunt of Covid-19 restrictions. The start of vaccinations in December should help sustain and hopefully bolster this increase in confidence for the year ahead.”

    Ed Thurman, Managing Director, Global Transaction Banking, Lloyds Bank Commercial Banking, added: “It’s encouraging to see news of a viable vaccine boost business confidence for the next 12 months. We are nearing the end of a year that has forced firms to dig deeper than ever before, and lean on the resilience and innovation they have always shown in the face of adversity.

    “But we are not out of the woods yet. The rollout of the vaccine will take time, and the path of the UK’s recovery from Covid-19 will continue to be determined by a far-reaching set of factors, including the end of the Brexit transition period on December 31st.”

    More from Finance

    Explore more articles in the Finance category

    Image for US wants Russia, Ukraine to end war by summer, Zelenskiy says
    US wants Russia, Ukraine to end war by summer, Zelenskiy says
    Image for Russia launches massive attack on Ukraine's energy system, Zelenskiy says
    Russia launches massive attack on Ukraine's energy system, Zelenskiy says
    Image for Russia launched 400 drones, 40 missiles to hit Ukraine's energy sector, Zelenskiy says
    Russia launched 400 drones, 40 missiles to hit Ukraine's energy sector, Zelenskiy says
    Image for The Kyiv family, with its pets and pigs, defying Russia and the cold
    The Kyiv family, with its pets and pigs, defying Russia and the cold
    Image for Two Polish airports reopen after NATO jets activated over Russian strikes on Ukraine
    Two Polish airports reopen after NATO jets activated over Russian strikes on Ukraine
    Image for French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    Image for Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Image for Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Image for Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Image for Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Image for Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Image for Big Tech's quarter in four charts: AI splurge and cloud growth
    Big Tech's quarter in four charts: AI splurge and cloud growth
    View All Finance Posts
    Previous Finance PostHow SMEs Can Support Their Finance Department During a Pandemic
    Next Finance PostHow much do we really value good financial advice?